Mesoblast Stock Quote MSB - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.48

Bid

1.48

Ask

1.49

Volume

0.00

0.00 Day's Range 0.00

0.255 52 Week Range 1.83

Market Cap

1.09B

Previous Close

1.48

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

4,658,839

Shares Outstanding

736,578,315

Dividend Yield

PE Ratio

-12.40

Earnings Per Share (EPS)

-0.12

Revenue

9.25M

Net Profit

-87.96M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.mesoblast.com

Headquarters

Melbourne, Victoria, Aus

Founded

Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker MSB. The last closing price for Mesoblast was AUD1.48. Over the last year, Mesoblast shares have traded in a share price range of AUD 0.255 to AUD 1.83.

Mesoblast currently has 736,578,315 shares outstanding. The market capitalization of Mesoblast is AUD1.09 billion. Mesoblast has a price to earnings ratio (PE ratio) of -12.40.

Mesoblast Gets FDA's Special Pediatric Designation for Revascor Heart Treatment

By Dean Seal Mesoblast said regulators have granted their rare pediatric disease designation to its cell therapy Revascor for children with hypoplastic left heart syndrome. The Australian...

Mesoblast ADSs Plunge Premarket on Latest FDA Rejection

By Colin Kellaher American depositary shares of Mesoblast plummeted more than 65% in premarket trading Friday after the biopharmaceutical company's latest setback in its bid to win U.S. Food...

FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing

Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD) Currently Being Reviewed PDUFA Goal Date August 2, 2023 If Approved, Remestemcel-L will be...

Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission

By Colin Kellaher American depositary shares of Mesoblast Ltd. jumped more than 15% in early trading Wednesday after the biopharmaceutical company said the U.S. Food and Drug Administration...

Mesoblast Shares Rise 11% After Resubmitting Biologics License Application

By Chris Wack Mesoblast Ltd. shares were up 11% to $3.67 Wednesday after the company said it resubmitted a biologics license application to the U.S. Food and Drug Administration seeking approval...

Mesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-L

By Chris Wack Mesoblast Ltd. shares were up 10% to $2.80 after the company said it submitted substantial new information to the U.S. Food and Drug Administration on clinical and potency assay...

Mesoblast to Hold Type C Meeting With FDA for Back Pain Treatment

By Chris Wack Mesoblast Ltd. said it has filed a request and expects to hold a Type C meeting with the U.S. Food & Drug Administration during the current quarter to discuss the pathway to U.S...

Mesoblast Up 25% After Hours on Collaboration With Novartis

By Josh Beckerman Mesoblast Ltd. American depositary receipts surged 25% to $14.70 after hours as the company entered an exclusive worldwide license and collaboration agreement with Novartis AG...

Mesoblast Named Global Technology Leader in Cell Therapy Industry

Mesoblast Limited has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry. Mesoblast is a biopharma company specializing in cell...

Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment of Acute Graft Versus Host Disease

MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., has...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.26	-14.9425287356	1.74	1.83	1.515	7569925	1.66208865	DE
4	0.105	7.63636363636	1.375	1.83	1.255	4068972	1.50472403	DE
12	0.52	54.1666666667	0.96	1.83	0.915	4658839	1.30426794	DE
26	0.4	37.037037037	1.08	1.83	0.88	5642572	1.16738409	DE
52	1.115	305.479452055	0.365	1.83	0.255	6881735	0.86435208	DE
156	-0.245	-14.2028985507	1.725	1.83	0.255	3765307	0.85199672	DE
260	-0.315	-17.5487465181	1.795	5.7	0.255	4391703	1.93099246	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HIQOHitIQ Limited	AUD 0.022 (633.33%)	25k
ARDOArgent Minerals Ltd	AUD 0.003 (200.00%)	18.41M
IFGInFocus Group Holdings Ltd	AUD 0.038 (153.33%)	61.11M
ADNOCAndromeda Metals Limited	AUD 0.002 (100.00%)	5M
FNRFar Northern Resources Ltd	AUD 0.18 (71.43%)	142.69k
OECROrbital Corporation Limited	AUD 0.001 (-98.48%)	9
ADXOADX Energy Limited	AUD 0.011 (-63.33%)	875k
CDECodeifai Ltd	AUD 0.001 (-50.00%)	82.68M
CRIOCritica Ltd	AUD 0.001 (-50.00%)	5M
AGEOCAlligator Energy Limited	AUD 0.01 (-28.57%)	36k
SYASayona Mining Limited	AUD 0.034 (-10.53%)	96.47M
CDECodeifai Ltd	AUD 0.001 (-50.00%)	82.68M
88E88 Energy Limited	AUD 0.002 (33.33%)	79.47M
PENPeninsula Energy Ltd	AUD 0.0545 (-3.54%)	72.33M
LPDLepidico Ltd	AUD 0.002 (0.00%)	65.86M